TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Capra Science Antibodies AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,166
|
5,771
|
5,776 |
Financial expenses |
36
|
12
|
7 |
Earnings before taxes |
200
|
679
|
623 |
EBITDA |
577
|
952
|
840 |
Total assets |
3,897
|
4,758
|
3,289 |
Current assets |
1,947
|
2,759
|
1,928 |
Current liabilities |
972
|
1,863
|
1,447 |
Equity capital |
2,543
|
2,385
|
1,842 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
3
![]() |
3
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
65.3%
|
50.1%
|
56.0% |
Turnover per employee |
1,722
|
1,924
|
1,444 |
Profit as a percentage of turnover |
3.9%
|
11.8%
|
10.8% |
Return on assets (ROA) |
6.1%
|
14.5%
|
19.2% |
Current ratio |
200.3%
|
148.1%
|
133.2% |
Return on equity (ROE) |
7.9%
|
28.5%
|
33.8% |
Change turnover |
-605
|
-5
|
427 |
Change turnover % |
-10%
|
0%
|
8% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-25%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.